News

Asieris Announced Closing of Series B Funding Round in Excess of 100 Million RMB

Asieris Pharmaceuticals Invited to Participate at Bio Partnering APAC 2017

Asieris Pharmaceuticals Invited to Present at the 20th Annual Meeting of CSCO

Asieris Pharmaceuticals Participated at 2017 BIO International Convention

Asieris Pharmaceuticals to Participate at 2017 BIO International Convention

Asieris Pharmaceuticals Presented at the 2017 ChinaBio? Partnering Forum

TV Interview at Kick-off Meeting for the Pivotal Trial of Asieris’ Anti-Bladder Cancer Drug

Asieris to Present at 6th Annual Drug Repositioning, Repurposing and Rescue Conference

Asieris announced first patient in APL-1202 pivotal trial

Asieris announced initiation of APL-1202 pivotal clinical trial